Cell culture involves the growth of living cells in laboratory conditions without using animals in order to gain better understanding of body function, disease or to develop new drugs. Conventionally, cells are grown in 2-D glass or plastic surfaces such as Petri-dishes and plates, and are normally cultured in isolation, ignoring multiple cell types important in maintaining tissue function. However, no cell lives alone in the human body and creating multiple cell type tissue models are essential to mimic the true nature of organ specific function and improve research and drug discovery.
Researchers across many sectors, including the pharmaceutical industry, research organisations and universities apply conventional cell culture for the growth and testing of mammalian cells. Cell culture has played a vital role in many life science discoveries such as the development of new drugs or vaccines. However, the results often lack relevance when tested in patients as the cell growth is constrained within the available 2-D surface when compared to true three-dimensional (3-D) complex multicellular environments of living tissue.
Drug-induced liver injury (DILI) and neurotoxicity are leading causes of drug failure during development and post-market drug withdrawal. There is a need for a more predictive tools to assess liver and neurotoxicity risks early in drug discovery. Human cell-based laboratory models for pre-clinical safety screening are increasingly being developed as alternative methods to animal testing.
Revivocell Ltd is developing a novel Organ-on-a-chip (OOAC) cell culture platform, that can better simulate the environment for cells to enhance their function, for example as a liver in an _in-vitro_ setting. Existing 3-D cell culture technologies aiming to promote liver specific functionality are expensive, difficult to use and are not easily adaptable for different experiments and cell types.
This technology has the potential to increase the success rate of developing new treatments and reduce the reliance on animal testing. The objective of this project is to assess the feasibility of a newly developed OOAC technology to mimic the liver and neuro-specific microenvironment. Revivocell's invention will provide a reliable, fast and cost effective device that could be used worldwide
"Drug-induced liver injury (DILI) is one of the leading cause of drug failure during development as well as number one cause of post-market drug withdrawal. There is a need for a more predictive tools to assess liver toxicity risks early in drug discovery. Human cell based laboratory models for safety screening are increasingly being developed as alternative methods to animal testing.
Cell culture involves the growth of living cells in laboratory conditions without using animals in order to gain better understanding of body function, disease or to develop new drugs. Conventionally, cells are grown in 2-D glass or plastic surfaces such as Petri-dishes and plates.
Researchers across many sectors, including pharmaceutical industry, research organisations and universities apply conventional cell culture for the growth and testing of mammalian cells. Cell culture has played a vital role in many life science discoveries such as the development of new drugs or vaccines. However, the results often lack efficiency as cell growth is constrained within the available 2-D surface when compared to true three-dimensional (3-D) environments of living tissue.
ReVivoCell Ltd is developing a novel cell culture platform, that can better simulate the function of the liver in an _in-vitro_ setting. Existing 3-D cell culture technologies lack liver specific functionality, are expensive, difficult to use and are not easily adaptable for different experiments and cell types.
This technology would potentially increase the success rate of developing new treatments and reduce the reliance on animal testing. The objective of this project is to assess the feasibility of a newly developed 3-D cell culture platform to mimmic liver-specific microenvironment. ReVivoCell's invention will provide a reliable, fast and cost effective device that could be used worldwide."
Cell culture is a process whereby living cells are grown in laboratory conditions without using animals in order to gain better understanding of body function, disease or to develop new drugs. Traditionally, cells have been grown in hard and flat 2-D surfaces, either in glass or plastic, a technology that has not changed significantly since the invention of the Petri dish by Julius Richard Petrie in 1870s. Researchers across many sectors, including pharmaceutical industry, research organisations and universities apply conventional cell culture for the growth and testing of mammalian cells. Cell culture has played a vital role in many life science discoveries such as the development of new drugs or vaccines. However, the results often lack efficiency as cell growth is constrained within the available 2-D surface when compared to true three-dimensional (3-D) environments of living tissue. ReVivoCell Ltd is developing a novel device for the growth of cell cultures, in laboratory condition, that can mimic the function of living tissue much more closely. Existing technology for 3-D cell culture is expensive, difficult to use and not easily adaptable for different experiments and cell types. This technology would potentially increase the success rate of developing new treatments and reduce the reliance on animal testing. The objective of this project is to assess the feasibility of a newly developed 3-D cell culture device. ReVivoCell's invention will provide a reliable, fast and cost effective device that could be used worldwide.
Osteoporosis is an incredibly debilitating disease. More than 3 million people in the UK are estimated to suffer and it effects 1 in 2 women and 1 in 5 men over the age of 50. It leads to increased risk of bone fractures, reduced quality of life and increased morbidity and mortality. More that 40% of people who experience fractures live with long-term pain. The cost of osteoporosis to the NHS is around £1.5 billion, and up to 69,000 people are admitted as a result of hip fracture accidents each year. There is a clear need to improve predicting those who are at risk of developing osteoporsis and growing evidence that prescribing the appropriate treatment based on an individual's condition can lead to better management of osteoporosis, reduced risk of fracture and delay acute disease onset. Revivocell and Lancaster University plan to collaborate to develop a new method of early diagnosis that will not only assist clinicians to prescribe more effective therapeutics, but also inform at risk patients. The emerging techology is based on advances in combining cell culture technologies and spectrometry, to develop new techniques for improved diagnosis.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process whereby living cells are grown in laboratory conditions for various
scientific experiments, without using animals, for example: to gain better understanding of
bodily function, disease processes or to develop new drugs. Traditionally, cells have been
grown in hard and flat 2-D (two-dimensional) surfaces, either in glass or plastic, and this
technology has not changed significantly since the invention of the Petri dish by Julius
Richard Petri in 1870s. Researchers across many sectors, including pharmaceutical industry,
research organisations and universities primarily apply conventional cell culture for the
growth of mammalian cells, bacteria or viruses. Cell culture has played a vital role in many
Life Science discoveries such as the development of new drugs or vaccines. However, the
results often lack applicability as the cell growth is constrained within the available 2-D
surface when compared to the real-world 3-D environment of living tissue. Revivocell Ltd has
begun to develop a novel device for the growth of cell cultures in 3-D forms, under laboratory
conditions; these can mimic the function of living tissue much more closely. This technology
would potentially increase the success rate of developing new treatments and reduce the
reliance on animal testing. The objective of this application is to assess the market potential of
our newly-developed patent pending device. Revivocell’s invention will provide a reliable,
fast and cost-effective device that could be used worldwide in Life Sciences laboratories with
a potential to become a standard method.
Cell culture is a process where living cells are cultured in the laboratory setting without using animals for various scientific experiments including to understanding body function, disease and to develop new drugs. Traditionally, cells have been grown in hard and flat 2D surface such as in glass or plastic and this technology has not changed significantly since the invention of the Petridish by Julius Richard Petri in 1870s. Researchers across many sectors such as Pharmaceutical industry, Research organisations and Universities apply conventional cell culture for the growth of mammalian cells, bacteria and viruses. Cell culture has played a vital role in in many life sciences discoveries such as the development new drugs, however, the results often lack efficiency do to the constrained 2D surface where cells are grown when compared to real 3D environment of the living tissue. Revivocell Ltd had begun to develop a novel laboratory device that can mimic the function of living tissue much more closely in an in...